The transaction has been completed.
The acquisition includes Verenium’s oilseed processing business and IP portfolio, licenses for certain food enzymes and access to biodiversity libraries that Verenium will create using proprietary technology. The sales of these businesses are estimated at about $15m, growing rapidly in the coming years.
With the acquisition of these assets and licenses DSM will strengthen its industrial biotech activities and reinforce its food enzymes innovation pipeline, the company said.
Verenium is headquartered in San Diego (California, US). It has developed a number of high-performance enzyme products and product candidates for use in industrial processes.
Verenium’s enzyme products minimise pollution by reducing or replacing harsh chemicals used in industrial processes while also enhancing yields in their customers’ processes.
DSM acquired Verenium’s oilseed processing business, including the R&D portfolio and partnership agreements. As part of the agreement, a number of Verenium employees will be offered to transfer to DSM.
Verenium has developed Purifine, an enzyme that offers crop-based oil producers a sustainable way to improve yields as well as overall processing economics. The annual market growth for enzymes in the global crop-based oil market is expected to be about 50% in the coming years with the market potential estimated at more than $350m.
DSM will have access to the newly developed bio-diversity collection and library being created by Verenium. By extracting microbial DNA directly from collected samples the slow and often impossible task of culturing individual microbes in a laboratory is avoided. Utilising ultra high-throughput screening technologies, Verenium mines its collection of billions of microbial genes in search of unique enzymes.
Stephen Tanda, member of the DSM managing board and responsible for the nutrition cluster, said: “This acquisition will broaden our enzymes business and fits very well in our strategy of continued value growth for our nutrition cluster. It will also further support our leading industrial biotechnology position.”
Source: DSM
© FoodBev Media Ltd 2024